Previous 10 | Next 10 |
NEW ORLEANS, May 01, 2020 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Ra Medical Systems, Inc. (NYSE: RMED). On ...
Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Joan Stafslien to its Board of Directors, effective April 24, 2020 and expanding Board membership to sev...
Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today announced it has granted an equity inducement award to Jonathan Will McGuire, the Company’s new chief executive officer...
Ra Medical Systems (NYSE: RMED ) appoints Will McGuire as Chief Executive Officer (CEO) and a member of Board of Directors, effective March 30. More news on: Ra Medical Systems, Inc., Second Sight Medical Products, Inc., Healthcare stocks news, Read more ...
Ra Medical Systems, Inc . (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Will McGuire as Chief Executive Officer and a member of the company’s Board of Directors, effe...
Ra Medical Systems, Inc. (RMED) Q4 2019 Earnings Conference Call March 10, 2020 4:30 PM ET Company Participants Jody Cain – LHA Investor Relations Andrew Jackson – Interim Chief Executive Officer and Chief Financial Officer Conference Call Participants Anthony V...
Ra Medical Systems (NYSE: RMED ): Q4 GAAP EPS of -$0.72 beats by $0.43 . More news on: Ra Medical Systems, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Conference call begins at 4:30 p.m. Eastern time today Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, reports financial results for the three and 12 months ended December...
Ra Medical Systems (NYSE: RMED ) announces the enrollment of the first patient in its study to evaluate the safety and effectiveness of the DABRA excimer laser system for use as an atherectomy device for the treatment of peripheral vascular stenoses. More news on: Ra Medical Systems, ...
Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces enrollment of the first patient in its pivotal study to evaluate the safety and effectiveness of the DABRA excimer laser sy...
News, Short Squeeze, Breakout and More Instantly...
Ra Medical Systems Inc. Company Name:
RMED Stock Symbol:
NYSE Market:
Ra Medical Systems Inc. Website:
Name change to Catheter Precision, Inc. is effective on August 17, 2023, with trading under new ticker symbol VTAK to begin on August 18, 2023 FORT MILL, SC / ACCESSWIRE / August 17, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced that its Board of Directors has approved cha...
First patent out of six applications on file for LockeT product FORT MILL, SC / ACCESSWIRE / August 14, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced that it has received notification of allowance of the first patent to be issued for the company's LockeT product. Ent...
Catheter Precision's VIVO System Has Been Utilized in over 1,000 Procedures FORT MILL, SC / ACCESSWIRE / August 7, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced today that VIVO, the lead product for the electrophysiology division, has been used in more than 1000 ventricula...